¼¼°èÀÇ ·¹Áö¿À³Ú¶ó±Õ °Ë»ç ½ÃÀå
Legionella Testing
»óǰÄÚµå : 1655463
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 02¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 173 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,464,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 25,393,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ ·¹Áö¿À³Ú¶ó±Õ °Ë»ç ½ÃÀåÀº 2030³â±îÁö 5¾ï 5,170¸¸ ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 3¾ï 4,300¸¸ ´Þ·¯·Î ÃßÁ¤µÇ´Â ¼¼°èÀÇ ·¹Áö¿À³Ú¶ó±Õ °Ë»ç ½ÃÀåÀº 2024-2030³â¿¡ CAGR 8.2%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 5¾ï 5,170¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ ¸®Æ÷Æ®¿¡¼­ ºÐ¼®ÇÑ ºÎ¹®ÀÇ ÇϳªÀÎ ¹è¾ç¹ýÀº CAGR 8.5%¸¦ ±â·ÏÇϸç, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 1¾ï 2,240¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ´¢ÁßÇ׿ø°Ë»ç(UAT) ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ Áß CAGR 8.6%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 8,840¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 12.1%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ·¹Áö¿À³Ú¶ó±Õ °Ë»ç ½ÃÀåÀº 2024³â¿¡ 8,840¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦´ë±¹ÀÎ Áß±¹Àº ºÐ¼® ±â°£ÀÎ 2024-2030³âÀÇ CAGRÀ» 12.1%·Î °ßÀÎÇϸç 2030³â±îÁö 1¾ï 3,890¸¸ ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±âŸ ÁÖ¸ñÇØ¾ß ÇÒ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß CAGRÀº °¢°¢ 4.3%¿Í 7.3%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 5.1%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ ·¹Áö¿À³Ú¶ó±Õ °Ë»ç ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

·¹Áö¿À³Ú¶ó±Õ °Ë»ç°¡ °¢ »ê¾÷ ºÐ¾ß¿¡¼­ Á߿伺ÀÌ ³ô¾ÆÁö´Â ÀÌÀ¯´Â ¹«¾ùÀΰ¡?

·¹Áö¿À³Ú¶ó±Õ °Ë»ç´Â °øÁߺ¸°Ç°ú ¹° ¾ÈÀü¿¡ ´ëÇÑ Àü ¼¼°èÀÇ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ±× Á߿伺ÀÌ Á¡Á¡ ´õ Ä¿Áö°í ÀÖ½À´Ï´Ù. ·¹Áö¿À³Ú¶ó±ÕÀº ÁÖ·Î »ó¼öµµ¿¡ Á¸ÀçÇÏ¸ç ½É°¢ÇÑ Æó·ÅÀÇ ÀÏÁ¾ÀÎ ·¹Áö¿À³Ú¶óÁõÀ» À¯¹ßÇÒ ¼ö ÀÖ½À´Ï´Ù. º´¿ø, È£ÅÚ, °ø°ø½Ã¼³°ú °°Àº ½Ã¼³¿¡¼­ ´ë±Ô¸ð ±Þ¼ö ½Ã½ºÅÛÀÌ ³Î¸® ÆÛÁ® ÀÖÀ¸¹Ç·Î ·¹Áö¿À³Ú¶ó ±Õ¿¡ ´ëÇÑ Á¤±âÀûÀÎ °Ë»ç´Â °¨¿° ¹ß»ýÀ» ¿¹¹æÇÏ°í °ÅÁÖÀÚÀÇ ¾ÈÀüÀ» º¸ÀåÇÏ´Â µ¥ ÇʼöÀûÀÔ´Ï´Ù. Á¤ºÎÀÇ ±âÁذú °øÁߺ¸°Ç Áöħ¿¡ µû¶ó °Ç°­°ú ¾ÈÀü¿¡ ´ëÇÑ ±ÔÁ¦¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁü¿¡ µû¶ó ƯÈ÷ ¹° ¾ÈÀü Á¤Ã¥ÀÌ ¾ö°ÝÇÑ Áö¿ª¿¡¼­´Â Àû±ØÀûÀÎ ·¹Áö¿À³Ú¶ó±Õ °Ë»çÀÇ Çʿ伺ÀÌ ´õ¿í Ä¿Áö°í ÀÖ½À´Ï´Ù.

·¹Áö¿À³Ú¶ó±Õ °Ë»ç ½ÃÀåÀÇ ±â¼ú ¹ßÀüÀº?

±â¼úÀÇ ¹ßÀüÀº ·¹Áö¿À³Ú¶ó±Õ °Ë»ç¸¦ º¸´Ù ºü¸£°í, Á¤È®Çϰí, ´Ù¾çÇÑ ¼ö°è¿¡¼­ ½±°Ô ¼öÇàÇÒ ¼ö ÀÖµµ·Ï º¯È­½ÃÄ×½À´Ï´Ù. ¸·´ëÇÑ ½ÇÇè ½Ã°£ÀÌ ÇÊ¿äÇÑ ÀüÅëÀûÀÎ ¹è¾ç ¹æ¹ýÀº ÁßÇÕÈ¿¼Ò¿¬¼â¹ÝÀÀ(PCR) °Ë»ç, ½Å¼Ó¸é¿ªÃøÁ¤¹ý, È¿¼Ò°áÇո鿪ÈíÂø¹ý(ELISA)°ú °°Àº ÷´Ü ±â¼ú·Î º¸¿ÏµÇ°Å³ª ´ëüµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¹æ¹ýÀº ³ôÀº ¹Î°¨µµ¿Í ƯÀ̼ºÀ» Á¦°øÇÏ¿© ·¹Áö¿À³Ú¶ó±ÕÀ» ½Å¼ÓÇÏ°Ô °ËÃâÇϰí Á¤·®È­ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÈÞ´ë¿ë °Ë»ç ŰƮ¿Í ÀÚµ¿ »ùÇøµ ½Ã½ºÅÛÀ» ÅëÇØ ÇöÀå °Ë»ç°¡ °¡´ÉÇØÁ® ÇöÀå °Ë»ç°¡ °¡´ÉÇØÁ³½À´Ï´Ù. ½Ç½Ã°£ ¸ð´ÏÅ͸µ ¹× Á¶±â °¨Áö ±â´ÉÀ» ÅëÇØ ÀÌ·¯ÇÑ Çõ½ÅÀº ·¹Áö¿À³Ú¶ó±Õ °Ë»çÀÇ ½Å·Ú¼ºÀ» ³ôÀÌ°í »ê¾÷°è°¡ º¸´Ù ¾ö°ÝÇÑ ¹° °ü¸® ÇÁ·ÎÅäÄÝÀ» äÅÃÇÒ ¼ö ÀÖ°Ô ÇØÁÝ´Ï´Ù.

¾î¶² ¾÷°è¿¡¼­ ·¹Áö¿À³Ú¶ó±Õ °Ë»ç¸¦ äÅÃÇϰí Àִ°¡?

±ÔÁ¦ Áؼö¿Í °øÁߺ¸°Ç¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁü¿¡ µû¶ó ÀÇ·á, Á¢°´¾÷, ¹° °ü¸® ¾÷°è´Â ·¹Áö¿À³Ú¶ó±Õ °Ë»ç¸¦ ¼±µµÀûÀ¸·Î µµÀÔÇϰí ÀÖ½À´Ï´Ù. º´¿ø ¹× ¿ä¾ç½Ã¼³¿¡¼­´Â ¾àÀÚ¸¦ º¸È£Çϱâ À§ÇØ ·¹Áö¿À³Ú¶ó °Ë»ç¸¦ ÀÚÁÖ »ç¿ëÇϰí, ¼÷¹Ú¾÷°è¿¡¼­´Â Åõ¼÷°´ÀÇ ¾ÈÀüÀ» º¸È£Çϱâ À§ÇØ ·¹Áö¿À³Ú¶ó °Ë»ç¸¦ »ç¿ëÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ »ê¾÷ ½Ã¼³, ±³À° ±â°ü ¹× Áö¹æ ÀÚÄ¡ ´ÜüÀÇ »ó¼öµµ ½Ã½ºÅÛÀº ȯ°æ À§»ý ±ÔÁ¤À» ÁؼöÇϱâ À§ÇØ ¹° ¾ÈÀü °èȹ¿¡ ·¹Áö¿À³Ú¶ó °Ë»ç¸¦ ÅëÇÕÇϰí ÀÖ½À´Ï´Ù. Àü ¼¼°è¿¡¼­ Áö¼Ó°¡´ÉÇÑ ¹° °ü¸® °üÇàÀ» Àå·ÁÇÏ´Â ¿òÁ÷ÀÓÀº »ê¾÷°è°¡ Á¾ÇÕÀûÀÎ ¹° À§Çè Æò°¡ÀÇ ÀÏȯÀ¸·Î ·¹Áö¿À³Ú¶ó °Ë»ç¸¦ µµÀÔÇϵµ·Ï ´õ¿í Ã˱¸Çϰí ÀÖ½À´Ï´Ù.

·¹Áö¿À³Ú¶ó±Õ °Ë»ç ½ÃÀåÀÇ ¼ºÀåÀº ¸î °¡Áö ¿äÀο¡ ÀÇÇØ ¹ß»ýÇÑ´Ù

·¹Áö¿À³Ú¶ó±Õ °Ë»ç ½ÃÀåÀÇ ¼ºÀåÀº °Ç°­¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, ±ÔÁ¦ ¿ä°Ç, °Ë»ç ¹æ¹ýÀÇ ±â¼ú ¹ßÀü µî ¿©·¯ °¡Áö ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ¼±Áø±¹°ú ½ÅÈï ±¹°¡ÀÇ ¼öÁú ±ÔÁ¦ °­È­·Î ÀÎÇØ °¢ ±â°üµéÀÌ ·¹Áö¿À³Ú¶ó ¹æÁö ÇÁ·Î±×·¥À» ¿ì¼±¼øÀ§·Î »ï°í ÀÖ½À´Ï´Ù. Á¤±âÀûÀÎ °Ë»ç°¡ ÇÊ¿äÇÑ ÀÇ·á ½Ã¼³, È£ÅÚ ¹× ±âŸ °íÀ§Çè ȯ°æ Áõ°¡µµ ÁÖ¿ä ÃËÁø¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ½Å¼Ó °Ë»ç ¹× ÇöÀå Áø´Ü ÅøÀÇ Çõ½ÅÀ¸·Î ·¹Áö¿À³Ú¶ó±Õ °Ë»ç¿¡ ´ëÇÑ Á¢±Ù¼ºÀÌ È®´ëµÇ¾î ´Ù¾çÇÑ ºÎ¼­¿¡¼­ Á¤±âÀûÀÎ °Ë»ç¸¦ º¸´Ù ½±°í ºñ¿ë È¿À²ÀûÀ¸·Î ¼öÇàÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεéÀÌ °áÇÕµÇ¾î ½ÃÀåÀº »ó½Â¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù.

ºÎ¹®

¿ëµµ(ÀÓ»ó°Ë»ç¹ý, ȯ°æ°Ë»ç¹ý);&ÃÖÁ¾ ¿ëµµ(º´¿ø, Áø´Ü¿¬±¸¼Ò, Áø·á¼Ò, ±âŸ ÃÖÁ¾ ¿ëµµ);&°Ë»ç À¯Çü(¹è¾ç¹ý, ¼Òº¯ Ç׿ø °Ë»ç(UAT), Ç÷ûÇÐ, Á÷Á¢ Çü±¤ Ç×ü °Ë»ç(DFA), ÇÙ»ê ±â¹Ý °ËÃâ¹ý)

Á¶»ç ´ë»ó ±â¾÷ÀÇ ¿¹(ÁÖ¸ñ 41»ç)

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå °³¿ä

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Legionella Testing Market to Reach US$551.7 Million by 2030

The global market for Legionella Testing estimated at US$343.0 Million in the year 2024, is expected to reach US$551.7 Million by 2030, growing at a CAGR of 8.2% over the analysis period 2024-2030. Culture Methods, one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$122.4 Million by the end of the analysis period. Growth in the Urinary Antigen Test (UAT) segment is estimated at 8.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$88.4 Million While China is Forecast to Grow at 12.1% CAGR

The Legionella Testing market in the U.S. is estimated at US$88.4 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$138.9 Million by the year 2030 trailing a CAGR of 12.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.3% and 7.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.1% CAGR.

Global Legionella Testing Market - Key Trends & Drivers Summarized

Why Is Legionella Testing Gaining Importance Across Industries?

Legionella testing has become increasingly important as global awareness around public health and water safety intensifies. Legionella bacteria, primarily found in water systems, can cause Legionnaires' disease, a potentially severe form of pneumonia. Given the prevalence of large-scale water distribution systems in facilities like hospitals, hotels, and public buildings, regular testing for Legionella is essential to prevent outbreaks and ensure the safety of occupants. This rising focus on health and safety regulations, driven by government standards and public health guidelines, has elevated the need for proactive Legionella testing, particularly in regions with strict water safety policies.

How Is Technology Advancing in the Legionella Testing Market?

Technological advancements have transformed Legionella testing, making it faster, more accurate, and easier to conduct across various water systems. Traditional culture methods, which require extensive lab time, are being supplemented or replaced by advanced techniques like polymerase chain reaction (PCR) testing, rapid immunoassays, and enzyme-linked immunosorbent assay (ELISA) tests. These methods offer high sensitivity and specificity, allowing for faster detection and quantification of Legionella bacteria. Portable testing kits and automated sampling systems are now available, making it feasible to conduct on-site testing. With real-time monitoring and early detection capabilities, these technological innovations have made Legionella testing more reliable, allowing industries to adopt more stringent water management protocols.

Which Industries Are Embracing Legionella Testing?

The healthcare, hospitality, and water management industries are leading adopters of Legionella testing, driven by regulatory compliance and a heightened focus on public health. Hospitals and nursing homes rely on frequent Legionella testing to protect vulnerable populations, while the hospitality sector uses it to safeguard guests. Additionally, industrial facilities, educational institutions, and municipal water systems have integrated Legionella testing into their water safety plans to maintain compliance with environmental health regulations. The global push for sustainable water management practices has further encouraged industries to incorporate Legionella testing as part of comprehensive water risk assessments.

The Growth in the Legionella Testing Market Is Driven by Several Factors

The growth in the Legionella testing market is driven by several factors, including rising health awareness, regulatory requirements, and technological advancements in testing methodologies. Increased regulations around water quality in developed and emerging economies have spurred organizations to prioritize Legionella control programs. The growing number of healthcare facilities, hotels, and other high-risk environments that require regular testing is also a key driver. Additionally, innovations in rapid testing and on-site diagnostic tools have broadened access to Legionella testing, making it easier and more cost-effective for various sectors to implement routine testing. These factors collectively underscore the market's upward trajectory.

SCOPE OF STUDY:

The report analyzes the Legionella Testing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Application (Clinical Testing Methods, Environmental Testing Methods); End-Use (Hospitals, Diagnostic Laboratories, Clinics, Other End-Uses); Test Type (Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA), Nucleic Acid-based Detection)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â